top of page
News, Events and Updates
Search
Anavex President & CEO Christopher U. Missling, PhD, to present preclinical data on ANAVEX 2-73
May 16, 2017
Anavex Reports Fiscal Second Quarter 2017 Financial Results
May 9, 2017
Anavex Life Sciences Appoints Former FDA Officer as Senior Vice President of Regulatory Affairs
Apr 30, 2017
Anavex President & CEO Christopher U. Missling, PhD, to Participate in a Roundtable Discussion
Apr 20, 2017
New Mechanism of Action Data Related to ANAVEX Compounds Targeting Sigma-1 Receptor
Apr 2, 2017
The Dual Regulation of Oxidative Stress by SIGMA1 Receptors in Physiological/Pathological Conditions
Mar 31, 2017
Targeting M1 Muscarinic & Sigma1 Receptors in Alzheimer's Disease: Reversal of Pathological Hallmark
Mar 29, 2017
Anavex Life Sciences Reports Dismissal of Appeal in the Cortina Lawsuit
Mar 29, 2017
Anavex Presents at AD/PD 2017 Conference
Mar 28, 2017
Anavex Life Sciences to Present at Oppenheimer 27th Annual Healthcare Conference
Mar 14, 2017
Anavex Life Sciences to Present at 14th Annual BIO Asia International Conference
Mar 12, 2017
25
26
27
28
29
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
